The Hyderabad-based pharmaceutical company Bharat Biotech is currently in the final stages of developing the ‘intranasal jab’ for India. This ‘intranasal’ vaccine is suited for both children and adults. Bharat Biotech also developed India’s first Covid-19 vaccine called ‘Covaxin’ which is the most administered vaccine in India.
According to the official results released by the government body ‘Niti Aayog’. The officials of Niti Aayog said that the initial results of the ‘Intranasal’ vaccine have been promising. The vaccine is capable of preventing the virus from entering the body.
This vaccine is developed in collaboration with the Department of Biotechnology and Biotechnology Industry Research Associate Council (BIRAC). The vaccine will not require trained health workers to be administered. It is quite simple to take the intranasal jab yourself or with anyone’s assistance.
As of now, there is no clarity on when exactly this vaccine will be available in India. But it seems that this vaccine may be released within this year.
The following is the detailed news article by ‘Hindustan Times’ about the initial results of Bharat Biotech’s intranasal vaccine.